Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

NEOSTIGMINE OMEGA

OMEGA LABORATORIES LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is NEOSTIGMINE OMEGA discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that NEOSTIGMINE OMEGA 0.5MG has been permanently discontinued (last updated February 21, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is NEOSTIGMINE OMEGA not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products · 1 same form & route
Affected strength0.5MG
Report last updated2023-02-21
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NEOSTIGMINE METHYLSULFATE INJECTION USP

MARCAN PHARMACEUTICALS INC

0.5MG · DIN 02475480

Same strengthDifferent dosage formSame routeNo current shortage

NEOSTIGMINE METHYLSULFATE INJECTION, USP

JAMP PHARMA CORPORATION

0.5MG · DIN 02537516

Same strengthDifferent dosage formSame routeNo current shortage

NEOSTIGMINE OMEGA

OMEGA LABORATORIES LIMITED

1MG · DIN 02230592

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02230593

Strength

0.5MG

Dosage Form

LIQUID

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR

Active Ingredient

NEOSTIGMINE METHYLSULFATE

See all NEOSTIGMINE METHYLSULFATE products →

Shortage History